BioPharmSignal logoBioPharmSignal

Biotech News

OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital

OraSure Technologies, Inc. (OSUR)OraSure Technologies, Inc.2026-06-25 13:46 ESTCompany update

No Shareholder Action Required at This Time BETHLEHEM, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today confirmed that Altai Capital (“Altai”) has

Open original release

Related news

OSUROraSure Technologies, Inc.2026-06-25 13:46 EST

OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections

OSUROraSure Technologies, Inc.2026-06-25 13:46 EST

OraSure Announces First Quarter 2026 Financial Results

OSUROraSure Technologies, Inc.2026-06-25 13:46 EST

OraSure to Participate in Upcoming Investor Conference

OSUROraSure Technologies, Inc.2026-06-25 13:46 EST

OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates

OSUROraSure Technologies, Inc.2026-06-25 13:46 EST

OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review

OSUROraSure Technologies, Inc.2026-06-25 13:46 EST

OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th

OSUROraSure Technologies, Inc.2026-06-25 13:46 EST

OraSure to Launch OraQuick™ HIV Self-Test in Canada

OSUROraSure Technologies, Inc.2026-06-25 13:46 EST

OraSure Announces Fourth Quarter 2025 Financial Results

OSUROraSure Technologies, Inc.2026-06-25 13:46 EST

OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital

OSUROraSure Technologies, Inc.2026-06-25 13:46 EST

OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th

View all latest news

OraSure Technologies, Inc.

OraSure Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

OSUROraSure Technologies, Inc.2026-06-26 10:47 EST

OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections

OSUROraSure Technologies, Inc.2026-06-26 10:47 EST

OraSure Announces First Quarter 2026 Financial Results

OSUROraSure Technologies, Inc.2026-06-26 10:47 EST

OraSure to Participate in Upcoming Investor Conference

OSUROraSure Technologies, Inc.2026-06-26 10:47 EST

OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates

OSUROraSure Technologies, Inc.2026-06-26 10:47 EST

OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biotechnology
Location
United States